Inflammation, Microenvironment, and the Immune System in Cancer Progression

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|17|1949-1955

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.17, 2009-06, pp. : 1949-1955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 765-778

Bentham Science Publishers

Access to resources Recommend Favorite

The Immune System of Cancer Patients

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 4, 2011-08 ,pp. : 262-274

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Immune System in Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 166-184

Bentham Science Publishers

Access to resources Recommend Favorite

The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer

By  

Current Cancer Drug Targets, Vol. 17, Iss. 4, 2017-04 ,pp. : 325-332

Bentham Science Publishers

Access to resources Recommend Favorite

PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2843-2848

Bentham Science Publishers

Access to resources Recommend Favorite